# Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer

> **NCT00901537** · PHASE1 · TERMINATED · sponsor: **Loma Linda University** · enrollment: 8 (actual)

## Conditions studied

- Non-small Cell Lung Cancer
- Squamous Cell Carcinoma of the Head and Neck

## Interventions

- **DRUG:** Azacitidine and Cisplatin

## Key facts

- **NCT ID:** NCT00901537
- **Lead sponsor:** Loma Linda University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02
- **Primary completion:** 2011-09
- **Final completion:** 2011-10
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Sponsor terminated due to no enrollments within last 4 months.
- **Last updated:** 2018-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00901537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00901537, "Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00901537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*